Gerald L. Ray & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $6.59M | Sell |
81,292
-1,800
| -2% | -$146K | 0.82% | 28 |
|
|
2017
Q2 | $5.88M | Buy |
83,092
+8,067
| +11% | +$571K | 0.76% | 30 |
|
|
2017
Q1 | $5.1M | Buy |
75,025
+7,445
| +11% | +$506K | 0.7% | 35 |
|
|
2016
Q4 | $4.84M | Sell |
67,580
-900
| -1% | -$64.4K | 0.7% | 35 |
|
|
2016
Q3 | $5.42M | Buy |
68,480
+8,115
| +13% | +$642K | 0.81% | 31 |
|
|
2016
Q2 | $5.04M | Buy |
60,365
+450
| +0.8% | +$37.5K | 0.8% | 33 |
|
|
2016
Q1 | $5.5M | Buy |
59,915
+950
| +2% | +$87.3K | 0.89% | 30 |
|
|
2015
Q4 | $5.97M | Buy |
58,965
+1,550
| +3% | +$157K | 0.94% | 27 |
|
|
2015
Q3 | $5.64M | Buy |
57,415
+2,555
| +5% | +$251K | 0.94% | 26 |
|
|
2015
Q2 | $6.42M | Buy |
54,860
+380
| +0.7% | +$44.5K | 0.98% | 25 |
|
|
2015
Q1 | $5.35M | Sell |
54,480
-600
| -1% | -$58.9K | 0.8% | 33 |
|
|
2014
Q4 | $5.19M | Sell |
55,080
-2,110
| -4% | -$199K | 0.8% | 36 |
|
|
2014
Q3 | $6.09M | Sell |
57,190
-1,250
| -2% | -$133K | 0.99% | 30 |
|
|
2014
Q2 | $4.85M | Buy |
58,440
+940
| +2% | +$77.9K | 0.83% | 35 |
|
|
2014
Q1 | $4.07M | Buy |
57,500
+2,820
| +5% | +$200K | 0.74% | 39 |
|
|
2013
Q4 | $4.11M | Sell |
54,680
-440
| -0.8% | -$33K | 0.77% | 38 |
|
|
2013
Q3 | $3.47M | Buy |
55,120
+140
| +0.3% | +$8.8K | 0.72% | 41 |
|
|
2013
Q2 | $2.82M | Buy |
+54,980
| New | +$2.82M | 0.63% | 45 |
|